Used in peptide synthesis, particularly in the production of complex therapeutic peptides and research compounds. Its N-methyl and D-allo-isoleucine configuration enhances metabolic stability and influences peptide conformation, making it valuable in designing bioactive peptides with improved resistance to enzymatic degradation. The Fmoc group allows for mild, base-labile protection during solid-phase synthesis, enabling stepwise assembly of peptides without affecting other sensitive functional groups. Commonly applied in pharmaceutical development and biochemical studies where stereochemistry and peptide backbone modification are critical.